EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Other Sources: 3

Glucosamine and chondroitin

Also called: glucosamine sulfate, glucosamine hydrochloride, chondroitin sulfate

Constituents of joint cartilage. Glucosamine is a building block for glycosaminoglycans; chondroitin helps cartilage resist compression. Sold in the US as dietary supplements, separately or together.

Category
Other
Forms
Glucosamine sulfate or glucosamine hydrochloride; chondroitin sulfate
Strongest evidence
C Limited
Reviewed
2026-10-28

Class 1 Well studied in people. NCCIH cites a 2014 analysis of 25 studies of glucosamine taken alone for knee osteoarthritis (3,458 participants) and a 2019 analysis of 18 studies of chondroitin taken alone (3,791 participants). Both (Eriksen 2014; Honvo 2019) are meta-analyses of randomized placebo-controlled trials. [1]

Fact-checked 2026-10-28 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

5 topics studied1 body area · strongest grade C

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Glucosamine and chondroitin does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Glucosamine and chondroitin, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Knee osteoarthritis pain and functionCA 2018 analysis of 29 studies (6,120 participants) found pain reduced by glucosamine or chondroitin alone but not by the combination; individual studies were inconsistent, and NCCIH calls the benefit uncertain. [1]
Joint structure (joint-space narrowing) in knee osteoarthritisCTwo large 2-year trials conflicted: an Australian trial (605 participants) found less narrowing with the combination; a US trial (572 participants) found no difference from placebo. [1]
Hip osteoarthritis (glucosamine sulfate)XA 2-year trial in 222 participants found glucosamine sulfate no better than placebo for pain, function or joint-space narrowing. [1]
Hand osteoarthritis (chondroitin)COne 6-month study in 162 participants found less hand pain and better function with chondroitin than placebo. [1]
Temporomandibular joint osteoarthritis (glucosamine)CA review of 8 studies (538 participants) could not reach definite conclusions; studies differed in methods and products and some may have been biased. [1]

Main constituents: Glucosamine (sulfate or hydrochloride) [1]; Chondroitin sulfate [1]

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Score D
    A: well known causeE: unlikely cause

    LiverTox likelihood score D for glucosamine: possible rare cause of clinically apparent liver injury (chapter last updated March 12, 2018) …

    Details and sources
  • Pregnancy and breastfeeding
    NCCIH: little is known about the safety of glucosamine and chondroitin during pregnancy or while breastfeeding.

    2 statements in the profile.

    Details and sources
  • Interactions with medicines
    3 listed

    Warfarin; Warfarin; Anticoagulants and antiplatelet drugs

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    4 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    Stated

    Health Canada NNHPD Joint Health Products, Multiple Ingredient monograph (December 19, 2025), adults 18 years and older: glucosamine sulfate 1,500 …

    Details and sources
  • No major safety problems have been identified in large studies for osteoarthritis. [1]
  • Glucosamine may cause increases in blood glucose (sugar) levels in some people. [1]
  • Little is known about safety during pregnancy or while breastfeeding. [1]
Interactions

Interactions

Known interactions of Glucosamine and chondroitin
WithWhat happens
WarfarinGlucosamine and chondroitin have been associated with an increased risk of bleeding in people taking warfarin. [1]

Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.

Quality

Identity, quality and standardization

  • Studies using a prescription drug formulation of glucosamine generally had more favorable results; this may reflect real product differences or bias, as most were older, at high risk of bias and company-funded. [1]
  • For chondroitin, a 2019 analysis of low-bias studies found significant differences among brands, with one pharmaceutical-grade preparation showing a greater pain reduction. [1]
Regulation

Regulatory status

  • US: sold as dietary supplements. In some other countries, certain preparations are sold as prescription drugs. [1]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Glucosamine, as glucosamine sulfate (proper name 2-amino-2-deoxy-D-glucose sulfate) or glucosamine hydrochloride Amino sugar [P8]
  • Chondroitin sulfate (as sodium chondroitin sulfate) Polysaccharides (glycosaminoglycan) [P8]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 4 entries naming glucosamine or chondroitin (including salts and N-acetyl glucosamine) (earliest NDI 343 submitted 2005-08-29; most recent NDI 1188 submitted 2020-12-02). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P1]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of glucosamine or chondroitin was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P2]
  • The NTP Technical Reports index (TR-001 to TR-606) lists no 2-year study of glucosamine or chondroitin (checked 2026-10-29). [P3]

Liver (NIH LiverTox)

  • LiverTox likelihood score D for glucosamine: possible rare cause of clinically apparent liver injury (chapter last updated March 12, 2018); no separate score is given for chondroitin. [P6]

Interactions with medicines

  • Warfarin: NCCIH: glucosamine and chondroitin have been associated with an increased risk of bleeding in people taking warfarin. [P5]
  • Warfarin: MSK: glucosamine-chondroitin may potentiate warfarin effects and increase INR; more information is needed to define this interaction. [P7]
  • Anticoagulants and antiplatelet drugs: MSK: glucosamine may inhibit platelet aggregation. [P7]

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • In three US chondroitin sulfate and glucosamine supplements, measured contents were up to 68.8% lower than declared on labels, and the chondroitin was of mixed animal origin with variable molecular weight and undesired keratan sulfate (Stellavato et al., 2021). [P9]

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P4]
  • Chondroitin sulfate: compliance with the Chondroitin Sulfate Sodium monograph of the British, European or United States Pharmacopoeia — Required by Health Canada's joint health monograph unless the ingredient is covered by an authorized NHP Master File. [P8]
  • Assay of chondroitin sulfate and glucosamine content against label (e.g. HPAE-PAD, HPCE), with checks for animal origin and keratan sulfate — Label shortfalls of up to 68.8%, mixed animal origin and keratan sulfate were found in US supplements. [P9]
  • Bovine-sourced material: veterinary certificate and traceability for transmissible spongiform encephalopathy (TSE) risk — Health Canada requirement for ingredients sourced from bovine tissues. [P8]

Supply and conservation

  • LiverTox: glucosamine in dietary supplements is usually prepared from the exoskeletons of shellfish or from fermentation of grain. [P6]
  • Health Canada lists glucosamine sources as crab, krill, lobster, prawn or shrimp exoskeleton or fermentation (Aspergillus, Monascus or Rhizopus species), and chondroitin sulfate from cartilage of animals including cattle, pigs, chickens, turkeys and other birds. [P8]

Absorption in people

  • In 12 healthy volunteers given crystalline glucosamine sulfate once daily, glucosamine was rapidly absorbed; plasma levels rose more than 30-fold from baseline and peaked at about 10 µM at 1,500 mg, kinetics were linear from 750 to 1,500 mg but not at 3,000 mg, and the elimination half-life was tentatively estimated at 15 h. [P10]

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • Health Canada NNHPD Joint Health Products, Multiple Ingredient monograph (December 19, 2025), adults 18 years and older: glucosamine sulfate 1,500 mg/day; glucosamine hydrochloride 1,500–2,000 mg/day; chondroitin sulfate 800–1,200 mg/day. [P8]

Pregnancy and breastfeeding

  • NCCIH: little is known about the safety of glucosamine and chondroitin during pregnancy or while breastfeeding. [P5]
  • Health Canada's joint health monograph requires the label caution to ask a health care practitioner before use if pregnant or breastfeeding. [P8]

Sources for this profile

  1. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  2. IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1–142 (last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
  3. National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606), 2026-10-29. ntp.niehs.nih.gov
  4. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  5. NCCIH. Glucosamine and Chondroitin for Osteoarthritis: What You Need To Know (Last Updated: October 2023), 2023-10. nccih.nih.gov
  6. NIH LiverTox (NIDDK). Glucosamine (Last Update: March 12, 2018), 2018-03-12. ncbi.nlm.nih.gov
  7. Memorial Sloan Kettering Cancer Center. About Herbs: Glucosamine (last updated September 30, 2026), 2026-09-30. mskcc.org
  8. Health Canada NNHPD. Natural health product monograph: Joint Health Products, Multiple Ingredient (date December 19, 2025), 2025-12-19. webprod.hc-sc.gc.ca
  9. Stellavato A, et al. Chondroitin sulfate in USA dietary supplements in comparison to pharma grade products: analytical fingerprint and potential anti-inflammatory effect on human osteoartritic chondrocytes and synoviocytes. Pharmaceutics 2021;13(5):737 (PMID 34067775), 2021-05-17. pubmed.ncbi.nlm.nih.gov
  10. Persiani S, et al. Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man. Osteoarthritis Cartilage 2005;13(12):1041-1049 (PMID 16168682), 2005-12. pubmed.ncbi.nlm.nih.gov
Sources

Sources

  1. NCCIH. Glucosamine and Chondroitin for Osteoarthritis: What You Need To Know (Last Updated: October 2023), 2023-10. nccih.nih.gov
  2. Eriksen P, et al. Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials. Arthritis Care Res (Hoboken) 2014;66(12):1844-55 (PMID 24905534), 2014-12. pubmed.ncbi.nlm.nih.gov
  3. Honvo G, et al. Efficacy of Chondroitin Sulfate in Patients with Knee Osteoarthritis: A Comprehensive Meta-Analysis Exploring Inconsistencies in Randomized, Placebo-Controlled Trials. Adv Ther 2019;36(5):1085-1099 (PMID 30879253), 2019-05. pubmed.ncbi.nlm.nih.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in this category: Alpha-lipoic acid · Bee pollen · Beetroot juice (dietary nitrate) · Berberine · Beta-glucan (oat and barley) · Betaine (trimethylglycine) · Bromelain · Caffeine · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.